Chen et al. also showed that a high miR-107 expression inhibits glioma cell proliferation, invasion and down-regulates the expression of Notch2, stem cell markers CD133, Nestin and MMP-12 in the U87GSC cell line, thus indicating its potential therapeutic role in glioma treatment [160]. The gene discussed is PROM1; the disease is central nervous system cancer.